Literature DB >> 31805451

The ketogenic diet: Pros and cons.

Blair O'Neill1, Paolo Raggi2.   

Abstract

Diets have been at the center of animated debates for decades and many claims have been made in one direction or the other by supporters of opposite camps, often with limited evidence. At times emphasis has been put on a single new aspect that the previous diets had overlooked and the new one was to embrace in order to improve weight loss and well-being. Unfortunately, very few randomized clinical trials involving diets have addressed the combined question of weight loss and cardiovascular outcomes. The recently introduced ketogenic diet requires a rigorous limitation of carbohydrates while allowing a liberal ingestion of fats (including saturated fats) and has generated a flurry of interest with many taking the pro position and as many taking the cons position. The ketogenic diet causes a rapid and sensible weight loss along with favourable biomarker changes, such as a reduction in serum hemoglobin A1c in patients with diabetes mellitus type 2. However, it also causes a substantial rise in low density lipoprotein cholesterol levels and many physicians are therefore hesitant to endorse it. In view of the popular uptake of the keto diet even among subjects not in need of weight loss, there is some preoccupation with the potential long-term consequences of a wide embrace of this diet by large segments of the population. On the contrary, numerous lines of evidence show that plant-based diets are associated with reduction in oncological and cardiovascular diseases and a prolonged life span. The debate reproduced in this article took place during a continuous medical education program between two cardiologists with largely differing views on the matter of effectiveness, sustainability, and safety of the ketogenic diet compared to alternative options.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31805451     DOI: 10.1016/j.atherosclerosis.2019.11.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

Review 1.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

2.  Low-dose 1,3-butanediol reverses age-associated vascular dysfunction independent of ketone body β-hydroxybutyrate.

Authors:  Cameron G McCarthy; Emily W Waigi; Beng San Yeoh; Blair Mell; Matam Vijay-Kumar; Camilla F Wenceslau; Bina Joe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-11       Impact factor: 4.733

Review 3.  The Blood-Brain Barrier: Much More Than a Selective Access to the Brain.

Authors:  Fredy Sanchez-Cano; Luisa C Hernández-Kelly; Arturo Ortega
Journal:  Neurotox Res       Date:  2021-10-22       Impact factor: 3.911

Review 4.  Keto is Trending: Implications for Body Weight and Lipid Management.

Authors:  Carol F Kirkpatrick; Kaye-Eileen Willard; Kevin C Maki
Journal:  Curr Cardiol Rep       Date:  2022-07-06       Impact factor: 3.955

Review 5.  The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.

Authors:  G Defeudis; M Rossini; Y M Khazrai; A M V Pipicelli; G Brucoli; M Veneziano; F Strollo; A Bellia; O Bitterman; D Lauro; D Mora; E Santarelli
Journal:  Eat Weight Disord       Date:  2022-07-01       Impact factor: 3.008

6.  Effects of early-life exposure to Western diet and voluntary exercise on adult activity levels, exercise physiology, and associated traits in selectively bred High Runner mice.

Authors:  Marcell D Cadney; Layla Hiramatsu; Zoe Thompson; Meng Zhao; Jarren C Kay; Jennifer M Singleton; Ralph Lacerda de Albuquerque; Margaret P Schmill; Wendy Saltzman; Theodore Garland
Journal:  Physiol Behav       Date:  2021-03-16

7.  Microecological preparation combined with an modified low-carbon diet improves glucolipid metabolism and cardiovascular complication in obese patients.

Authors:  Jianguo Liu; Liehui Xiao; Hezhongrong Nie; Yong Pan; Yan Liu; Zhentian Zhang; Xiuping Lin; Yuan Zhang; Jinchuang Cai; Muxiu Yang; Yajing Liu; Leijun Zhang; Aimin Xu; Cuifeng Zhu
Journal:  Diabetol Metab Syndr       Date:  2021-07-13       Impact factor: 3.320

Review 8.  Ten things to know about ten cardiovascular disease risk factors ("ASPC Top Ten - 2020").

Authors:  Harold Edward Bays
Journal:  Am J Prev Cardiol       Date:  2020-05-01

Review 9.  Benefits of Low Carbohydrate Diets: a Settled Question or Still Controversial?

Authors:  Matthew J Landry; Anthony Crimarco; Christopher D Gardner
Journal:  Curr Obes Rep       Date:  2021-07-23

Review 10.  Ten things to know about ten cardiovascular disease risk factors.

Authors:  Harold E Bays; Pam R Taub; Elizabeth Epstein; Erin D Michos; Richard A Ferraro; Alison L Bailey; Heval M Kelli; Keith C Ferdinand; Melvin R Echols; Howard Weintraub; John Bostrom; Heather M Johnson; Kara K Hoppe; Michael D Shapiro; Charles A German; Salim S Virani; Aliza Hussain; Christie M Ballantyne; Ali M Agha; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2021-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.